| Use of real-time ultrasound guidance for the placement of hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials KS Rabindranath, E Kumar, R Shail, E Vaux American journal of kidney diseases 58 (6), 964-970, 2011 | 119 | 2011 |
| Applications and analysis of targeted genomic sequencing in cancer studies F Bewicke-Copley, EA Kumar, G Palladino, K Korfi, J Wang Computational and structural biotechnology journal 17, 1348-1359, 2019 | 116 | 2019 |
| Ultrasound use for the placement of haemodialysis catheters KS Rabindranath, E Kumar, R Shail, EC Vaux Cochrane Database of Systematic Reviews, 2011 | 87 | 2011 |
| Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐or immunotherapy TA Fox, E Troy‐Barnes, AA Kirkwood, WY Chan, JW Day, SJ Chavda, ... British journal of haematology 191 (2), 194-206, 2020 | 79 | 2020 |
| Clinical characteristics and outcomes of HIV-associated immune complex kidney disease JW Booth, L Hamzah, S Jose, C Horsfield, P O'Donnell, S McAdoo, ... Nephrology Dialysis Transplantation 31 (12), 2099-2107, 2016 | 79 | 2016 |
| Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation E Kumar, L Pickard, J Okosun British Journal of Haematology 194 (5), 810-821, 2021 | 42 | 2021 |
| KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas J Heward, L Koniali, A D’Avola, K Close, A Yeomans, M Philpott, ... Blood, The Journal of the American Society of Hematology 138 (5), 370-381, 2021 | 39 | 2021 |
| Renal tubular disease in the era of combination antiretroviral therapy L Hamzah, JW Booth, S Jose, SP McAdoo, EA Kumar, P O’Donnell, ... Aids 29 (14), 1831-1836, 2015 | 31 | 2015 |
| Precision medicine and lymphoma JA Heward, EA Kumar, K Korfi, J Okosun, J Fitzgibbon Current opinion in hematology 25 (4), 329-334, 2018 | 9 | 2018 |
| The biological basis of histologic transformation EA Kumar, J Okosun, J Fitzgibbon Hematology/Oncology Clinics 34 (4), 771-784, 2020 | 6 | 2020 |
| Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma S Araf, K Korfi, F Bewicke-Copley, J Wang, S Cogliatti, E Kumar, F Forrer, ... haematologica 105 (6), 318, 2020 | 6 | 2020 |
| Follicular lymphoma genomics E Kumar, J Okosun HemaSphere 3, 79-81, 2019 | 2 | 2019 |
| Spectrum of HIV-associated kidney disease in the era of combination antiretroviral therapy JW Booth, SP McAdoo, EA Kumar, T Turner-Stokes, P Das, C Naftalin Kidney Week–American Society of Nephrology. Atlanta, GA, 2013 | 2 | 2013 |
| LONGITUDINAL ANALYSES OF DIAGNOSTIC‐RELAPSE BIOPSIES OF DIFFUSE LARGE B CELL LYMPHOMA SUGGEST THAT RELAPSE IS MEDIATED BY DISTINCT MECHANISMS IN ABC AND GCB LYMPHOMA K Korfi, S Araf, F Bewicke‐Copley, E Kumar, T Cummin, M Ashton‐Key, ... Hematological Oncology 37, 142-143, 2019 | 1 | 2019 |
| Culturally tailored education to South Asian (SA) populations in Auckland successfully promotes early screening and prevention of cardiovascular diseases (CVD) and Diabetes P Chhichhia, FA Khan, E Kumar, N Young Obesity Research & Clinical Practice, 59, 2011 | 1 | 2011 |
| Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma F Bewicke-Copley, K Korfi, S Araf, B Hodkinson, E Kumar, T Cummin, ... Blood Advances 7 (5), 845-855, 2023 | | 2023 |
| Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation M Perrett, L Pickard, E Kumar, G Palladino, F Khan, C Edmondson, ... Blood 140 (Supplement 1), 748-749, 2022 | | 2022 |
| The Paradoxical Efficacy of KDM6 Inhibition in Germinal Centre B-Cell Lymphomas K Close, H Armes, E Kumar, F Bewicke-Copley, A Cribbs, J Dunford, ... Blood 138, 3289, 2021 | | 2021 |
| Response to'Impact of immunosuppression on mortality in critically ill COVID-19 patients' TA Fox, E Troy-Barnes, AA Kirkwood, WY Chan, JW Day, SJ Chavda, ... British Journal of Haematology 191 (3), 505-506, 2020 | | 2020 |
| Longitudinal Analyses of Diagnostic-Relapse Biopsies of Diffuse Large B Cell Lymphoma Reveal a Poor Risk Subset of ABC Patients Based on the Expression of a 30 Gene Panel F Bewicke-Copley, K Korfi, S Araf, EA Kumar, TEC Cummin, ... Blood 134, 2769, 2019 | | 2019 |
